In early March, Verily Life Sciences, one of Alphabet’s biotech arms, announced it would turn its attention to fighting the pandemic. Internally, it was called
In early March, Verily Life Sciences, one of Alphabet’s biotech arms, announced it would turn its attention to fighting the pandemic. Internally, it was called
